Vimta Labs Profit & Loss Annual

BSE: 524394 | NSE: VIMTALABS | ISIN: INE579C01029 | Sector: Biotechnology & Drugs

866.15 +105.35 (13.85%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	318.26	318.19	278.28	210.68
Total Revenue	318.26	318.19	278.28	210.68
Costof Revenue Total	76.29	73.85	79.20	61.11
Gross Profit	241.98	244.34	199.08	149.57
Selling/ General/ Admin Expenses Total	99.28	149.14	118.43	95.99
Depreciation/ Amortization	34.20	30.71	23.33	23.08
Unusual Expense( Income)	0.00	0.00	1.22	-
Other Operating Expenses Total	55.90	0.29	0.14	0.17
Total Operating Expense	265.67	253.99	222.32	180.35
Operating Income	52.60	64.20	55.96	30.33
Interest Inc( Exp) Net- Non- Op Total	-21.22	-21.64	-11.61	-17.48
Other Net	4.01	2.72	0.85	-0.02
Net Income Before Taxes	54.48	65.00	55.69	28.54
Provisionfor Income Taxes	13.47	16.83	14.36	7.14
Net Income After Taxes	41.01	48.17	41.33	21.41
Net Income Before Extra Items	41.01	48.17	41.33	21.41
Net Income	41.01	48.17	41.33	21.41
Income Availableto Com Excl Extra Ord	41.01	48.17	41.33	21.41
Income Availableto Com Incl Extra Ord	41.01	48.17	41.33	21.41
Diluted Net Income	41.01	48.17	41.33	21.41
Diluted Weighted Average Shares	2.25	2.26	2.26	2.21
Diluted EPS Excluding Extra Ord Items	18.24	21.35	18.32	9.68
DPS- Common Stock Primary Issue	2.00	2.00	2.00	2.00
Diluted Normalized EPS	18.24	21.27	18.71	9.69
Gain( Loss)on Saleof Assets	-	2.44	0.42	-0.17